Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details)

v3.20.1
STOCKHOLDERS' EQUITY (DEFICIT) (Details) - $ / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Stockholders' Equity (Deficit):    
Number of warrants outstanding, beginning 644,083 208,333
Number of warrants granted 1,578,549 435,750
Number of warrants cancelled 0 0
Number of warrants exercised 0 0
Number of warrants forfeited (208,333) 0
Number of warrants outstanding, ending 2,014,299 644,083
Weighted average exercise price outstanding, beginning $ 177 $ 4.80
Weighted average exercise price granted .45 .32
Weighted average exercise price cancelled .00 .00
Weighted average exercise price exercised .00 .00
Weighted average exercise price forfeited 4.80 .00
Weighted average exercise price outstanding, ending .45 $ 177
Weighted average exercise price exercisable .45  
Weighted average fair value of warrants granted during the period $ 1.05  
Weighted average remaining contractual life outstanding, beginning 1 year 4 months 17 days 1 year 6 months
Weighted average remaining contractual life granted 5 years 1 year 9 months 15 days
Weighted average remaining contractual life outstanding, ending 3 years 3 months 22 days 1 year 4 months 17 days